-
Security Type
-
Debt
-
Categories
-
Retail, Beauty & Personal Care, Life Sciences
-
Min Investment
-
$250
-
Offering Date
-
September 28, 2021
-
Expected Close Date
-
April 30, 2022
-
Target Raise
-
$200.00K-$1.07M
-
Security Price
-
$1
- Number of Employees
- 2
- Cash
- $1,189
- Revenue
- $0
- Short Term Debt
- $1,212
- Cost of Goods
- $0
- Long Term Debt
- $0
- Net Income
- $-12,754
Company Description
📈 Huge market opportunity >$1B annually for an unmet medical & aesthetic need, growing at 15% CAGR
🚀 FDA 510(k) authorization (Rx & OTC) submitted after successfully completing testing requirements
🏆 Patent issued on utility, composition, design, and formulation(s)
👨🏾🔬👨🏼⚕️ Co-founders are scientist with 15 yrs industry experience and oculoplastic surgeon
🛠 Exclusive manufacturing agreement and production line with an international manufacturer
💰 Founders-funded and seeking a SAFE round for team build-up, Series A, & 2022 commercialization
Key Deal Facts
Huge market opportunity >$1B annually for an unmet medical & aesthetic need, growing at 15% CAGR
FDA 510(k) authorization (Rx & OTC) submitted after successfully completing testing requirements
Patent issued on utility, composition, design, and formulation(s)
Co-founders are scientist with 15 yrs industry experience and oculoplastic surgeon
Exclusive manufacturing agreement and production line with an international manufacturer
Founders-funded and seeking a SAFE round for team build-up, Series A, & 2022 commercialization
Management Team / Advisory Board Bios
Ahmad Tawil, Co-Founder & Chief Executive Officer
Expert in the medical aesthetic space with 15 years of industry experience (PwC/Strategy&, Monitor Group, GE Healthcare). Previous founder of Axelleron, SaaS for healthcare companies to manage commercialization.
Ronald Mancini, Co-Founder
World renowned oculoplastic, orbital, eyelid, and cosmetic facial surgeon. Training in Beverly Hills and at UCLA Medical Center. Member of the American Academy of Cosmetic Surgery, American Society of Ophthalmic Plastic and Reconstructive Surgery.
Reveal the Score by Voting
＿
Additional ratings from other users are needed to determine a viable CrowdScore for this deal.
The "CrowdScore" for this deal is determined by user ratings and other factors using our proprietary algorithm.
ⓘ
The overall viability and scalability of the business concept as well as the ability to drive the concept to profitability over time.
Business Idea
ⓘ
The progress made thus far in demonstrating that the business has viability, a customer base or other business traction.
Business Traction
ⓘ
The experience of the management team in running, scaling and/or exiting a business that required similar skills to execute the business plan.
Management Team
ⓘ
The value of the company compared to similar companies raising money from investors.
Valuation
Security Description
Debt is something, usually money, borrowed by one party from another. Debt is used by many corporations and individuals to make large purchases that they could not afford under normal circumstances. A debt arrangement gives the borrowing party permission to borrow money under the condition that it is to be paid back at a later date, usually with interest.